|
Synonyms: compound 352 [WO2023141432] | MXE-829 | MXE829 | MZE829
Compound class:
Synthetic organic
Comment: Alcedaplin (MXE829) is an apolipoprotein L1 (APOL1) inhibitor/modulator that is proposed to treat APOL1-associated nephropathy, particularly in individuals with a high-risk APOL1 genotype [1]. It is designed to inhibit both APOL1 pore formation and channel function.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Alcedaplin (MXE829) inhibits calcium transport by APOL1 with an AC50 (half-maximal activity concentration) of 597 nM [1]. |